Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 223,788 | 97,675 | 111,792 | 141,838 | 133,011 |
| Marketable Securities | 72,318 | 80,595 | 79,454 | 27,472 | 48,058 |
| Receivables | 59,383 | 45,611 | 40,394 | 38,744 | 33,767 |
| Inventories | 13,852 | 12,355 | 10,754 | 7,792 | 6,912 |
| TOTAL | $375,646 | $241,996 | $249,063 | $221,259 | $226,972 |
| Non-Current Assets | |||||
| PPE Net | 8,217 | 8,302 | 8,376 | 6,882 | 6,839 |
| Intangibles | 126,290 | 127,565 | 132,993 | 138,422 | 148,138 |
| Other Non-Current Assets | 1,620 | 1,548 | 1,221 | 1,157 | 1,129 |
| TOTAL | $136,127 | $137,415 | $142,590 | $146,461 | $156,106 |
| Total Assets | $511,773 | $379,411 | $391,653 | $367,720 | $383,078 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,666 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 82,534 | 71,437 | 76,446 | 64,054 | 63,996 |
| Other current liabilities | 2,274 | 1,279 | 1,665 | 1,723 | 1,387 |
| TOTAL | $86,474 | $72,716 | $82,048 | $71,899 | $67,985 |
| Non-Current Liabilities | |||||
| Long Term Debt | 147,204 | 146,878 | 144,971 | 143,091 | 141,242 |
| Deferred Revenues | N/A | N/A | 3,937 | 6,122 | 2,602 |
| Other Non-Current Liabilities | 153 | 209 | 243 | 269 | 292 |
| TOTAL | $157,897 | $156,387 | $153,168 | $149,939 | $145,362 |
| Total Liabilities | $244,371 | $229,103 | $235,216 | $221,838 | $213,347 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,714 | 46,446 | 41,796 | 41,490 | 41,389 |
| Common Shares | 47 | 42 | 42 | 41 | 41 |
| Retained earnings | -839,624 | -830,105 | -814,108 | -815,378 | -781,640 |
| Other shareholders' equity | 1,855 | 4,953 | 3,969 | 3,013 | 1,999 |
| TOTAL | $267,402 | $150,308 | $156,437 | $145,882 | $169,731 |
| Total Liabilities And Equity | $511,773 | $379,411 | $391,653 | $367,720 | $383,078 |